Bradycardia – a slower than normal heartbeat – does not increase the risk of developing cardiovascular disease, according to a study conducted by researchers at Wake Forest Baptist Medical Center. The study is published in the Jan.19 online edition of the Journal of American Medical Association Internal Medicine.
Global Genomics Group (G3) and GNS Healthcare (GNS), announced preliminary results of the GLOBAL Clinical Study designed to identify biomarkers associated with coronary artery disease (CAD). The study provided proof of concept of the approach by prospectively identifying a biochemical pathway known to be associated with CAD.
Vivasure Medical announced Conformité Européenne (CE) Mark approval of the world’s first fully bioabsorbable percutaneous vascular closure device for large-bore femoral arteriotomies.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Medtronic plc announced that the IN.PACT Admiral drug eluting balloon (DEB) has received CE (Conformité Européene) Mark for arteriovenous (AV) access to help maintain hemodialysis access in patients with end-stage renal disease.
2016 is starting off a whole lot better than last year for 14-year-old Oswaldo Jimenez of Salem, Ore. Last year at this time, he was sick. Life-threateningly sick. Diagnosed with pulmonary arterial hypertension at age 9, his heart and lungs were failing, and a heart-lung transplant seemed to be his only real hope for survival.
Biointegrated sensors for long-term, continuous tracking of body chemistry may make health and disease monitoring as easy as turning on your smartphone. Unveiled by Profusa Inc., of South San Francisco, Calif., tiny bioengineered biosensors will soon enable real-time detection of our body's unique chemistry, providing actionable, medical-grade data for personal and medical use for as long as two years at a time. The company's technology and vision were presented at the CES Digital Health Summit, Jan. 6-9 in Las Vegas.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Teleflex Inc. has acquired privately held Nostix LLC, developer of innovative tip confirmation systems that are used to increase the accuracy of vascular access device placement.
Patients between the ages of 40 and 70 who undergo aortic valve replacement (AVR) may fare better with tissue-based valves than metal-based valves, according to a review article posted online by The Annals of Thoracic Surgery.
CardioKinetix Inc. announced that it has enrolled more than half of the subjects in its pivotal United States trial, PARACHUTE IV. The trial is evaluating the Parachute device for the treatment of patients suffering from heart failure, a highly debilitating condition.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
The Centers for Medicare and Medicaid Services (CMS) announced Monday that it will be ending the Meaningful Use program that was meant to encourage the adoption of electronic medical records (EMR).
January 15, 2016 — The U.S. Food and Drug Administration (FDA) has given its approval for an expanded indication study ...
January 14, 2016 — Cornell biomedical engineers have discovered natural triggers that could reduce the chance of life ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Penumbra Inc. announced the U.S. launch of its new POD Packing Coil, designed as a complementary device for Penumbra’s Ruby and POD (Penumbra Occlusion Device) embolization products.
The American Medical Association (AMA) announced that it is investing $15M to become founding partner of a healthcare innovation company — Health2047 Inc.
Ionizing radiation can save lives, but it can also cause serious harm. Getting the right measurement of exposure to ionizing radiation in any situation is at the heart of an ISO standard that has recently been updated.